To investigate the association of MTX1 expression with HCC cell resistance to sorafenib, CCK-8 assay was used and the results indicated that MTX1 overexpression still maintained a higher cell growth rate compared with control cells under the treatment of sorafenib (Figure 3A). Here, MTX1 is linked to hepatocellular carcinoma.